COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 199 filers reported holding PACIRA PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 0.70 and the average weighting 0.3%.

Quarter-by-quarter ownership
COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$286,958
-2.1%
10,030
+0.0%
0.00%0.0%
Q1 2024$293,018
-13.3%
10,028
+0.1%
0.00%0.0%
Q4 2023$338,109
-64.5%
10,021
-67.7%
0.00%
-75.0%
Q3 2023$952,062
-54.3%
31,032
-40.3%
0.01%
-50.0%
Q2 2023$2,083,039
+5.1%
51,985
+7.0%
0.02%
-5.9%
Q1 2023$1,982,591
+104467.0%
48,581
-1.1%
0.02%
+6.2%
Q4 2022$1,896
-99.9%
49,104
+17.6%
0.02%
-27.3%
Q3 2022$2,221,000
-8.0%
41,751
+0.8%
0.02%
-15.4%
Q2 2022$2,415,000
-17.6%
41,420
+7.9%
0.03%
-10.3%
Q1 2022$2,931,000
+44.7%
38,401
+14.1%
0.03%
+38.1%
Q4 2021$2,026,000
+7.3%
33,666
-0.1%
0.02%
-4.5%
Q3 2021$1,888,000
-7.9%
33,706
-0.2%
0.02%
-4.3%
Q2 2021$2,050,000
-13.5%
33,785
-0.1%
0.02%
-20.7%
Q1 2021$2,371,000
+17.7%
33,827
+0.5%
0.03%
+3.6%
Q4 2020$2,014,000
+1.0%
33,654
+1.5%
0.03%
-28.2%
Q3 2020$1,994,000
+79.2%
33,167
+56.4%
0.04%
+85.7%
Q2 2020$1,113,000
+58.1%
21,203
+1.0%
0.02%
+31.2%
Q1 2020$704,000
+9.8%
20,996
+48.4%
0.02%
+45.5%
Q4 2019$641,000
+19.1%
14,148
+0.2%
0.01%
+10.0%
Q3 2019$538,000
-64.1%
14,122
-8.6%
0.01%
-54.5%
Q3 2014$1,497,000
+5.1%
15,450
-0.4%
0.02%
+4.8%
Q2 2014$1,424,000
+31.2%
15,5050.0%0.02%
+23.5%
Q1 2014$1,085,000
+21.8%
15,5050.0%0.02%
+21.4%
Q4 2013$891,000
-12.3%
15,505
-26.6%
0.01%
-17.6%
Q3 2013$1,016,00021,1300.02%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
ENDOWMENT ADVISERS LP 3,903$113,000100.00%
MPM ASSET MANAGEMENT LLC 824,255$23,903,00010.58%
Tamarack Capital Management, LLC 548,900$15,918,0008.92%
AlpInvest Partners B.V. 91,700$2,659,0002.53%
WALL STREET ASSOCIATES 761,709$22,090,0002.25%
GILDER GAGNON HOWE & CO LLC 4,118,765$119,444,185,0002.25%
Biondo Investment Advisors, LLC 177,490$5,147,0002.23%
MARXE AUSTIN W & GREENHOUSE DAVID M 499,829$14,495,0001.95%
Tygh Capital Management, Inc. 260,112$7,543,0001.67%
Visium Asset Management, LP 2,010,000$58,290,0001.36%
View complete list of PACIRA PHARMACEUTICALS INC shareholders